Electromed reports record Q3 revenue of $13.9M, up 15% YoY; net income $0.17 diluted EPS vs $0.12

Electromed, Inc.

2024-Q3 EPS reported $0.38 revenue$39,884,000

Revenue rose 14.9% YoY to a record $13.9M; net income $1.493M ($0.17 diluted) vs $1.075M ($0.12).
Operating income increased 54% to $1.841M (13% of revenue); gross margin held at 75%.
Direct homecare revenue grew 12% to $12.3M; 51 direct sales reps; annualized revenue per rep $969K above target range.
Cash balance $11.7M, up $4.3M in nine months; no debt; working capital $35.0M.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Electromed, Inc. reported the three months ended March 31, 2024 results: revenue $13.9 million, net income $1,493,000, EPS $0.17 per diluted share.

Period: the three months ended March 31, 2024
Revenue: $13.9 million
Net income: $1,493,000
EPS: $0.17 per diluted share
Result: reported results

Exact text from the filing

Net revenues increased 15% to a record $13.9 million in Q3 FY 2024, from $12.1 million in the third quarter of the prior fiscal year. ● Gross margins were 75% of net revenues in the third quarters of both the current and prior fiscal years. ● Operating income increased by 54% to $1,841,000 or 13% of revenue, compared with $1,196,000 or 10% of revenue in the third quarter of the prior fiscal year. ● Net income was $1,493,000 for the quarter, or $0.17 per diluted share, compared to $1,075,000, or $0.12 per diluted share in the third quarter of the prior fiscal year.

View on SEC.gov

710 earnings releases filed in the last 30 days. Browse all earnings releases →

Electromed, Inc. filing history →

Source: SEC EDGAR

accession 0000897101-24-000162

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.